We are live on ! Find out more
APVO icon

Aptevo Therapeutics
APVO

1 hedge funds and large institutions have $8.62M invested in Aptevo Therapeutics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more capital invested

Capital invested by funds: $7.44M → $8.62M (+$1.19M)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
$491K
Puts
–
Net Calls
+$491K
Net Calls Change
+$50K

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$4.98M

Top Sellers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
-$106K
2
BCM
Bridgeway Capital Management
Texas
-$55K
3
ARTA
A.R.T. Advisors
New York
-$41K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$37K
5
CL
CSS LLC
Illinois
-$36K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$2.73M +$4.98M +1 New
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$1.6M – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$1.56M – – –
PWAM
4
Park West Asset Management
California
$654K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$567K – – –
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$354K – – –
WVP
7
Worth Venture Partners
New Jersey
$246K – – –
BlackRock
8
BlackRock
New York
$201K – – –
UBS Group
9
UBS Group
Switzerland
$115K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$94K – – –
FM
11
Fondren Management
Texas
$79K – – –
WG
12
Winton Group
United Kingdom
$74K – – –
BFM
13
Boothbay Fund Management
New York
$51K – – –
Northern Trust
14
Northern Trust
Illinois
$51K – – –
CIBC Asset Management
15
CIBC Asset Management
Ontario, Canada
$46K – – –
Bank of New York Mellon
16
Bank of New York Mellon
New York
$37K – – –
ACA
17
Atlas Capital Advisors
Wyoming
$32.1K – – –
CSIC
18
Clifford Swan Investment Counsel
California
$18K – – –
PAG
19
Private Advisor Group
New Jersey
$16K – – –
California Public Employees Retirement System
20
California Public Employees Retirement System
California
$14K – – –
AG
21
Algert Global
California
$13K – – –
VF
22
Virtu Financial
New York
$13K – – –
SWA
23
SFMG Wealth Advisors
Texas
$10K – – –
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$10K – – –
State Street
25
State Street
Massachusetts
$8K – – –
1
2

APVO Hedge Fund Activity: Q4 2019 in Review

1 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Aptevo Therapeutics (APVO) for Q4 2019, worth a combined $8.62M — up 16% from $7.44M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new APVO positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $4.98M. The largest seller was Sessa Capital, cutting an estimated $106K.

  • 1 institutional investor held Aptevo Therapeutics (APVO) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $8.62M of Aptevo Therapeutics stock for Q4 2019, up 16% quarter-over-quarter.
  • 1 fund opened new Aptevo Therapeutics positions in Q4 2019 and 0 closed out, a net change of +1 holder.
  • The largest Aptevo Therapeutics buyer in Q4 2019 was Stonepine Capital Management, an estimated $4.98M added.
  • The largest Aptevo Therapeutics seller in Q4 2019 was Sessa Capital, an estimated $106K sold.

Based on aggregated 13F filings for Q4 2019.